Ascendis Pharma A/S (ASND) vs Corcept Therapeutics Incorporated (CORT)
Ascendis Pharma A/S and Corcept Therapeutics Incorporated are both Biotechnology companies. Ascendis Pharma A/S is the larger, with a market value of $15.7B against $12.9B — 1.2× the size. Ascendis Pharma A/S trades at the lower P/E: 16.3× against 223×. Ascendis Pharma A/S grew revenue faster over the last twelve months: 126.0% against 16.0%. Ascendis Pharma A/S has the higher net margin (71.2% vs 6.53%) and the higher return on invested capital (15.1% vs 1.01%). Across the 22 metrics below, Ascendis Pharma A/S leads on 19 and Corcept Therapeutics Incorporated on 3.
Valuation
Profitability
| Metric | ASND | CORT | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.26% | 98.30% | 65.16% |
| Operating margin | 24.84% | 0.77% | 0.00% |
| Net margin | 71.20% | 6.53% | 0.00% |
| Free cash flow margin | 31.97% | 12.87% | 0.00% |
| Return on equity | 118.44% | 8.08% | (57.72%) |
| Return on assets | 44.34% | 6.41% | (49.22%) |
| Return on invested capital | 15.07% | 1.01% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack